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Abstract 
 
A 64-year-old lady presented with a brief history of abdominal pain associated with obstructive jaundice. Endoscopic 
retrograde cholangiopancreaticography (ERCP) revealed a short segment stricture with contact bleeding and the 
brush cytology confirmed presence atypical cells. Ca 19.9 levels were markedly elevated. She was planned for a 
Whipple’s procedure but was instead subjected to a total pancreatectomy based on intraoperative findings of a 
diffusely hard and nodular pancreas. Histopathological examination confirmed our diagnosis of diffuse pancreatic 
adenocarcinoma. This rare presentation of a locally contained and fully resectable diffuse pancreatic adenocarcinoma 
is being discussed. 
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Introduction 
 
Diffuse pancreatic adenocarcinoma is a rare variation 
of pancreatic adenocarcinoma representing less than 
5% of all pancreatic malignancies. Commonly, a 
diffusely diseased pancreas would manifest as a 
metastatic pancreatic carcinoma with its patients 
presenting in an advanced state of disease where 
management would solely be palliative. We report a 
case of diffuse pancreatic adenocarcinoma confined to 
the pancreas and our management of this patient. 
 
Case Report  
 
A 64-year-old Malay lady presented with a 2 week 
history of worsening abdominal pain, jaundice, loss of 
appetite and progressive weight loss. Her liver profile 
showed an obstructive picture, while an abdominal 
ultrasound showed a dilated biliary tree with sludge in 
the gallbladder. She was then subjected to an 
endoscopic retrograde cholangiopancreaticography  
(ERCP) which revealed a short segment stricture of 
the distal common bile duct (CBD) with proximal 
dilatation and contact bleeding of the ampulla. 
Although tumour markers revealed a mildly raised 
CA 19.9, an abdominal CT showed no pancreatic 
mass or any other suspicious lesion. A repeat ERCP 
with brush cytology however confirmed presence of 
malignant cells, thus she was subjected to a 
Whipple’s procedure. Intraoperatively the entire 
pancreas was hard and nodular although the coeliac 
axis, porta hepatis and other surrounding structures 
showed no evidence of tumour infiltration. At this 
point, a differential diagnosis of chronic pancreatitis 
was entertained. However, frozen sections taken from 
the body of pancreas confirmed the presence of a 
malignancy. However, frozen sections of the 
suprapancreatic lymph nodes, were clear of tumour 
cells. In view of this, a total pancreatectomy was 
performed (Fig 1). Histopathological examination of 
the tumour revealed a moderately differentiated 
adenocarcinoma diffusely involving the entire 
pancreas up to 15mm from the tail with no lymphatic 
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infiltration and a clear surgical margin (Fig 2). A 
follow up review of the patient in the clinic 6 months 
later revealed no recurrence of symptoms. 
 
 
 
 
 
 
 
 
Discussion 
 
Diffuse morphology of pancreatic ductal 
adenocarcinoma is an unusual manifestation that 
represents only about 5% of all cases of pancreatic 
adenocarcinoma (1). To date, there is no pathologic 
definition to describe diffuse pancreatic 
adenocarcinoma. However, an earlier study defined 
diffuse disease by the involvement of a tumour of 
more than 50% along the longitudinal axis of the 
gland (2). The evolution of diffuse pancreatic 
adenocarcinoma is still debatable. While some believe 
that it is a result of rapid progression of an aggressive 
focal tumour others think that this may simply be 
attributed to a delayed diagnosis. The third 
postulation is a synchronous multifocal development 
of cancer thus exhibiting a diffuse involvement of the 
gland.  Extreme elevations of CA 19-9 levels has been 
demonstrated in patients with diffuse pancreatic 
adenocarcinoma (3). This has been postulated as due 
to the increased tumour burden in a diffusely involved 
gland as opposed to a focal lesion. However, the 
marked elevation of this enzyme by itself is 
inadequate to diagnose diffuse adenocarcinoma as it 
could also imply an advanced metastatic disease or 
other differentials such as pancreatic metastasis, 
lymphoma, and autoimmune or acute pancreatitis. 
The histological features of this condition is similar to 
that of focal lesions, however diffuse pancreatic 
adenocarcinoma commonly demonstrates all the 
aggressive characteristics of advanced cancer such as 
peripancreatic vascular invasion, direct invasion of 
neighboring structures, peritumoural infiltration, 
lymphadenopathy and distant metastasis. According 
to an earlier study on the radiological findings of 
either a peripheral capsule-like structure, the absence 
of main pancreatic duct dilatation within the tumour, 
no parenchymal atrophy and local invasiveness on 
computed tomography are believed to be 
characteristics of diffuse pancreatic adenocarcinoma.  
Our patient presented with the usual features of 
pancreatic cancer, however no clinical or radiological 
finding exhibited by her was keeping with those of 
diffuse disease as described above. We were also 
unable to answer the postulation regarding its 
evolution. Although only a 15 mm clear margin at the 
pancreatic tail was observed it remained focally 
confined to the pancreas which negates an aggressive 
focal disease or delayed diagnosis which would surely 
have spread beyond the margins of the pancreas. A 
multifocal theory was also questionable as our patient 
did not show an extreme increase in CA 19.9 levels in 
keeping with an increased tumour burden to the 
gland. Despite a retrospective review of the CT 
images, radiological findings that was expected in a 
diffuse pancreatic adenocarcinoma as described by 
earlier authors was also not seen in our patient . 
Finally, despite an extensive literature review no data 
was available regarding the outcome of diffuse 
pancreatic adenocarcinoma after resection when 
compared to focal disease. 
 We believe the information regarding characteristics 
of what is perceived to be diffused pancreatic 
adenocarcinoma are still rare and an audit on a larger 
scale is required in order to better understand this 
condition. A better understanding of this condition 
would have enabled us to plan better for our operative 
approach, prepared us for the expectant complications 
and prime the patient with regards to the effects, 
complications and outcome of a total pancreatectomy. 
 
 
Fig 1: En bloc resection including the spleen, pancreas, 
duodenum and the gallbladder 
Fig 2: Infiltration of malignant glandular epithelium 
into the pancreatic parenchyma (H&E; x20) 
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